Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytosorbents Corp (NASDAQ:CTSO)

5.43
Delayed Data
As of Mar 24
 +0.025 / +0.46%
Today’s Change
3.87
Today|||52-Week Range
6.90
-0.46%
Year-to-Date
No recent news for Cytosorbents Corp.

Today’s Trading

Previous close5.40
Today’s open5.45
Day’s range5.35 - 5.55
Volume31,307
Average volume (3 months)58,609
Market cap$137.8M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-42.42%
Earnings growth (this year)+12.23%
Earnings growth (next 5 years)--
Revenue growth (last year)+98.84%
P/E ratioNM
Price/Sales14.55
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CDTXCidara Therapeutics ...-0.20-2.68%
CDXCChromadex Corp-0.03-1.15%
NATRNatures Sunshine Pro...-0.35-3.68%
LFVNLifeVantage Corp+0.07+1.46%
Data as of 4:00pm ET, 03/24/2017

Financials

Next reporting dateMay 17, 2017
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$9.5M
Annual profit (last year)-$11.9M
Net profit margin-125.31%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Phillip P. Chan
Chief Operating Officer
Vincent Capponi
Corporate headquarters
Monmouth Junction, New Jersey

Forecasts


Search for Jobs